Who owns ALX ONCOLOGY HLDGS INC COM?
- Ticker: ALXO
- CUSIP Number: 00166b105
Tip: Access positions for across all investors
Analyze quarterly positions in Alx Oncology Hldgs with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Alx Oncology Hldgs stock
Who bought or sold ALX ONCOLOGY HLDGS INC COM this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| RA Capital Management | 13M | $26M | 100% | Mar 2026 |
|
| TCG Crossover Management | 13M | $26M | 100% | Mar 2026 |
|
| venBio Partners | 13M | $26M | 33% | Mar 2026 |
|
| Redmile Group | 8.0M | $16M | 144% | Mar 2026 |
|
| Blackstone Group | 5.8M | $12M | 100% | Mar 2026 |
|
| Vanguard Capital Management | 4.2M | $8.4M | 100% | Mar 2026 |
|
| Vivo Capital | 3.2M | $6.4M | 100% | Mar 2026 |
|
| Almitas Capital | 3.2M | $6.4M | 25% | Mar 2026 |
|
| 5AM Venture Management | 3.1M | $6.1M | 100% | Mar 2026 |
|
| OrbiMed Advisors | 2.9M | $5.7M | 100% | Mar 2026 |
|
| Millennium Management | 2.0M | $4.0M | -40% | Mar 2026 |
|
| Vanguard Group | 1.6M | $1.8M | 7% | Dec 2025 |
|
| Two Sigma Investments | 1.6M | $3.2M | 148% | Mar 2026 |
|
| Squadron Capital Management | 1.5M | $2.9M | 100% | Mar 2026 |
|
| Driehaus Capital Management | 1.4M | $1.6M | 79% | Dec 2025 |
|
| Acadian Asset Management | 1.1M | $2.2M | -20% | Mar 2026 |
|
| Ensign Peak Advisors | 951k | $1.9M | 100% | Mar 2026 |
|
| UBS Group | 915k | $1.8M | 6% | Mar 2026 |
|
| Bank of America Corporation | 578k | $1.2M | 100% | Mar 2026 |
|
| Geode Capital Management | 493k | $990k | 40% | Mar 2026 |
|
| BlackRock | 448k | $898k | -1% | Mar 2026 |
|
| Renaissance Technologies | 423k | $478k | 157% | Dec 2025 |
|
| Vanguard Fiduciary Trust | 295k | $590k | 100% | Mar 2026 |
|
| Susquehanna International | 184k | $208k | -2% | Dec 2025 |
|
| Northern Trust | 149k | $169k | 57% | Dec 2025 |
|
| Goldman Sachs Group | 139k | $278k | 703% | Mar 2026 |
|
| State Street Corporation | 124k | $140k | 11% | Dec 2025 |
|
| Bank of Nova Scotia | 106k | $212k | 0% | Mar 2026 |
|
| Morgan Stanley | 99k | $198k | 18% | Mar 2026 |
|
| Vanguard Portfolio Management | 98k | $196k | 100% | Mar 2026 |
|
| Jane Street | 95k | $191k | -54% | Mar 2026 |
|
| Ieq Capital | 92k | $104k | 0% | Dec 2025 |
|
| Brevan Howard Capital Management | 79k | $159k | 100% | Mar 2026 |
|
| Bridgeway Capital Management | 76k | $86k | 111% | Dec 2025 |
|
| OMERS Administration Corporation | 75k | $150k | 100% | Mar 2026 |
|
| GSA Capital Partners | 69k | $138k | -26% | Mar 2026 |
|
| Point72 Asset Management | 41k | $82k | 103% | Mar 2026 |
|
| Graham Capital Management | 38k | $76k | 100% | Mar 2026 |
|
| Citadel Advisors | 37k | $74k | -78% | Mar 2026 |
|
| Marshall Wace | 26k | $30k | -33% | Dec 2025 |
|
| HC Advisors | 23k | $46k | -4% | Mar 2026 |
|
| Callan Family Office | 22k | $45k | -21% | Mar 2026 |
|
| Caxton | 21k | $42k | 100% | Mar 2026 |
|
| Nine Masts Capital | 21k | $41k | 33% | Mar 2026 |
|
| JSF Financial | 18k | $35k | 0% | Mar 2026 |
|
| Moneta Group Investment Advisors | 15k | $31k | 0% | Mar 2026 |
|
| Virtu Financial | 14k | $15k | 100% | Dec 2025 |
|
| Lido Advisors | 13k | $27k | 0% | Mar 2026 |
|
| FMR | 13k | $15k | 0% | Dec 2025 |
|
| Abel Hall | 13k | $25k | 0% | Mar 2026 |
|
| Two Sigma Securities | 11k | $22k | 100% | Mar 2026 |
|
| Invesco | 11k | $22k | 100% | Mar 2026 |
|
| Barclays | 11k | $12k | 0% | Dec 2025 |
|
| Hsbc Holdings | 10k | $21k | 0% | Mar 2026 |
|
| Vanguard Global Advisers | 10k | $20k | 100% | Mar 2026 |
|
| Simplex Trading | 3.6k | $4.0k | 100% | Dec 2025 |
|
| Tower Research Capital | 3.1k | $3.6k | -18% | Dec 2025 |
|
| Royal Bank of Canada | 1.9k | $4.1k | 70% | Mar 2026 |
|
| NISA Investment Advisors | 1.1k | $2.2k | 0% | Mar 2026 |
|
| EverSource Wealth Advisors | 905.00 | $1.8k | 100% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 466.00 | $934.003800 | -3% | Mar 2026 |
|
| Pnc Financial Services | 100.00 | $201.000000 | 0% | Mar 2026 |
|
| CWM | 96.00 | $0 | -33% | Dec 2025 |
|
| Optiver Holding B.V. | 27.00 | $54.000000 | 0% | Mar 2026 |
|
| Citigroup | 17.00 | $34.000000 | 100% | Mar 2026 |
|
| SBI Securities | 14.00 | $28.000000 | -97% | Mar 2026 |
|
| Caitong International Asset Management | 6.00 | $12.000000 | 100% | Mar 2026 |
|
Who sold out of Alx Oncology Hldgs?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Two Sigma Advisers | Dec 2025 | 710k | $803k |
| Seven Fleet Capital Management | Dec 2025 | 118k | $133k |
| Jpmorgan Chase & Co | Sep 2025 | 62k | $113k |
| Nan Fung Trinity | Dec 2025 | 42k | $47k |
| DekaBank Deutsche Girozentrale | Dec 2025 | 41k | $508k |
| Wealth Enhancement Advisory Services | Dec 2025 | 38k | $41k |
| XTX Topco | Sep 2025 | 27k | $49k |
| Qube Research & Technologies | Sep 2025 | 17k | $31k |
| Commonwealth Equity Services | Dec 2025 | 15k | $17k |
| Bradley & Co. Private Wealth Management | Dec 2025 | 1.0k | $1.1k |
| Group One Trading | Dec 2025 | 518.00 | $584.977400 |